Trial Profile
Patient Preferences and Efficacy of TOBI Podhaler vs. Tobramycin Inhalation Solution
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Tobramycin (Primary)
- Indications Cystic fibrosis-associated respiratory tract infections
- Focus Therapeutic Use
- Acronyms PETIS
- Sponsors Rush University
- 27 Apr 2021 Status changed from recruiting to completed.
- 18 Feb 2014 New trial record